Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The acute phase of Trypanosoma cruzi infection is attenuated in 5-lipoxygenase-deficient mice.

Canavaci AM, Sorgi CA, Martins VP, Morais FR, de Sousa ÉV, Trindade BC, Cunha FQ, Rossi MA, Aronoff DM, Faccioli LH, Nomizo A.

Mediators Inflamm. 2014;2014:893634. doi: 10.1155/2014/893634. Epub 2014 Aug 3.

2.
3.

IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.

Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, Yoshida H.

J Immunol. 2010 Jul 15;185(2):1150-7. doi: 10.4049/jimmunol.0900047. Epub 2010 Jun 18.

4.
5.

Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88.

Campos MA, Closel M, Valente EP, Cardoso JE, Akira S, Alvarez-Leite JI, Ropert C, Gazzinelli RT.

J Immunol. 2004 Feb 1;172(3):1711-8.

6.

5-lipoxygenase is a key determinant of acute myocardial inflammation and mortality during Trypanosoma cruzi infection.

Pavanelli WR, Gutierrez FR, Mariano FS, Prado CM, Ferreira BR, Teixeira MM, Canetti C, Rossi MA, Cunha FQ, Silva JS.

Microbes Infect. 2010 Aug;12(8-9):587-97. doi: 10.1016/j.micinf.2010.03.016. Epub 2010 Apr 8.

PMID:
20381637
7.

Type I IFNs stimulate nitric oxide production and resistance to Trypanosoma cruzi infection.

Costa VM, Torres KC, Mendonça RZ, Gresser I, Gollob KJ, Abrahamsohn IA.

J Immunol. 2006 Sep 1;177(5):3193-200.

8.

[TH1 response in the experimental infection with Trypanosoma cruzi].

Cardoni RL, Antúnez MI, Abrami AA.

Medicina (B Aires). 1999;59 Suppl 2:84-90. Spanish.

PMID:
10668248
9.

Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection.

Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A.

J Immunol. 2006 Sep 15;177(6):3515-9.

10.

5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease.

Borges CL, Cecchini R, Tatakihara VL, Malvezi AD, Yamada-Ogatta SF, Rizzo LV, Pinge-Filho P.

Immunol Lett. 2009 Mar 24;123(1):38-45. doi: 10.1016/j.imlet.2009.02.002. Epub 2009 Feb 14.

PMID:
19428550
12.

Type I interferons increase host susceptibility to Trypanosoma cruzi infection.

Chessler AD, Caradonna KL, Da'dara A, Burleigh BA.

Infect Immun. 2011 May;79(5):2112-9. doi: 10.1128/IAI.01176-10. Epub 2011 Mar 14.

13.

IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice.

Araujo Z, Heremans H, Stordeur P, Wissing M, Goldman M, Castes M, Carlier Y.

Vaccine. 2000 Mar 6;18(17):1822-9.

PMID:
10699330
14.
15.

Neurodegeneration and increased production of nitrotyrosine, nitric oxide synthase, IFN-gamma and S100beta protein in the spinal cord of IL-12p40-deficient mice infected with Trypanosoma cruzi.

Bombeiro AL, D'Império Lima MR, Chadi G, Alvarez JM.

Neuroimmunomodulation. 2010;17(2):67-78. doi: 10.1159/000258689. Epub 2009 Nov 17.

16.

Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice.

Hölscher C, Mohrs M, Dai WJ, Köhler G, Ryffel B, Schaub GA, Mossmann H, Brombacher F.

Infect Immun. 2000 Jul;68(7):4075-83.

17.
18.

Perforin-expressing cytotoxic cells contribute to chronic cardiomyopathy in Trypanosoma cruzi infection.

Silverio JC, de-Oliveira-Pinto LM, da Silva AA, de Oliveira GM, Lannes-Vieira J.

Int J Exp Pathol. 2010 Feb;91(1):72-86. doi: 10.1111/j.1365-2613.2009.00670.x. Epub 2009 Oct 28.

19.
20.

Supplemental Content

Support Center